Dolan Matthew Vincent
EVP, Strategy &Corporate Dev | EVP Strategy And Corporate Dev | EVP Strategy &Corp Dev +3 more
1 company
Insider Signal Score
63
GoodTrades Analyzed
13
12M Win Rate
46.2%
Avg 3M Return
+9.6%
Avg 12M Return
+10.9%
Dolan Matthew Vincent is an EVP, Strategy &Corporate Dev at DXCM. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $3.6M at current prices.
Our model assigns Dolan Matthew Vincent a middling insider score of 63/100, based on 13 past trades. Over a 12-month horizon, 46.2% of those trades were profitable, with an average 12-month return of +10.9%.
Dolan Matthew Vincent's largest disclosed position is in DXCM as EVP, Strategy &Corporate Dev, worth about $3.6M. The recent filings there lean toward selling, a net 27,514 shares.
Holdings by Company
DXCMJan 29, 2025
Current Shares42.0K
Value$3.56M
Net Activity-27,514
Bought: 0Sold: 27.5K
Transaction History
Showing 1 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | DXCM Dexcom Inc | SVP Corporate Development | Sell | 2,186 | $424.68 | $928,358.56 | -9.2% | -37.1% | +0.2% |
← PrevPage 2